Cardiac arrhythmias during pregnancy

C. E L Brown, G. D. Wendel

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Arrhythmias of the pregnant patient are rare. In most cases, the therapeutic agent chosen should be much the same as that in the nonpregnant patient, and an understanding of the pharmacology of the antiarrhythmic agents is necessary for rational use in the pregnant patient with an arrhythmia. Substantial experience has been accumulated using some of the older agents for treatment of arrhythmias in pregnancy. As newer agents become available, there may be indications for their use in pregnancy; however, we recommend initially using well-known drugs until more experience is gained with the newer ones. The choice of an agent should be made only after thorough evaluation of the patient's symptoms, accurate diagnosis and an analysis of potential benefit versus potential risk to the mother or fetus.

Original languageEnglish (US)
Pages (from-to)89-102
Number of pages14
JournalClinical Obstetrics and Gynecology
Volume32
Issue number1
StatePublished - 1989

Fingerprint

Cardiac Arrhythmias
Pregnancy
Symptom Assessment
Fetus
Mothers
Pharmacology
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Brown, C. E. L., & Wendel, G. D. (1989). Cardiac arrhythmias during pregnancy. Clinical Obstetrics and Gynecology, 32(1), 89-102.

Cardiac arrhythmias during pregnancy. / Brown, C. E L; Wendel, G. D.

In: Clinical Obstetrics and Gynecology, Vol. 32, No. 1, 1989, p. 89-102.

Research output: Contribution to journalArticle

Brown, CEL & Wendel, GD 1989, 'Cardiac arrhythmias during pregnancy', Clinical Obstetrics and Gynecology, vol. 32, no. 1, pp. 89-102.
Brown, C. E L ; Wendel, G. D. / Cardiac arrhythmias during pregnancy. In: Clinical Obstetrics and Gynecology. 1989 ; Vol. 32, No. 1. pp. 89-102.
@article{c381a4edde544ff78fb78fc0b1567d75,
title = "Cardiac arrhythmias during pregnancy",
abstract = "Arrhythmias of the pregnant patient are rare. In most cases, the therapeutic agent chosen should be much the same as that in the nonpregnant patient, and an understanding of the pharmacology of the antiarrhythmic agents is necessary for rational use in the pregnant patient with an arrhythmia. Substantial experience has been accumulated using some of the older agents for treatment of arrhythmias in pregnancy. As newer agents become available, there may be indications for their use in pregnancy; however, we recommend initially using well-known drugs until more experience is gained with the newer ones. The choice of an agent should be made only after thorough evaluation of the patient's symptoms, accurate diagnosis and an analysis of potential benefit versus potential risk to the mother or fetus.",
author = "Brown, {C. E L} and Wendel, {G. D.}",
year = "1989",
language = "English (US)",
volume = "32",
pages = "89--102",
journal = "Clinical Obstetrics and Gynecology",
issn = "0009-9201",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cardiac arrhythmias during pregnancy

AU - Brown, C. E L

AU - Wendel, G. D.

PY - 1989

Y1 - 1989

N2 - Arrhythmias of the pregnant patient are rare. In most cases, the therapeutic agent chosen should be much the same as that in the nonpregnant patient, and an understanding of the pharmacology of the antiarrhythmic agents is necessary for rational use in the pregnant patient with an arrhythmia. Substantial experience has been accumulated using some of the older agents for treatment of arrhythmias in pregnancy. As newer agents become available, there may be indications for their use in pregnancy; however, we recommend initially using well-known drugs until more experience is gained with the newer ones. The choice of an agent should be made only after thorough evaluation of the patient's symptoms, accurate diagnosis and an analysis of potential benefit versus potential risk to the mother or fetus.

AB - Arrhythmias of the pregnant patient are rare. In most cases, the therapeutic agent chosen should be much the same as that in the nonpregnant patient, and an understanding of the pharmacology of the antiarrhythmic agents is necessary for rational use in the pregnant patient with an arrhythmia. Substantial experience has been accumulated using some of the older agents for treatment of arrhythmias in pregnancy. As newer agents become available, there may be indications for their use in pregnancy; however, we recommend initially using well-known drugs until more experience is gained with the newer ones. The choice of an agent should be made only after thorough evaluation of the patient's symptoms, accurate diagnosis and an analysis of potential benefit versus potential risk to the mother or fetus.

UR - http://www.scopus.com/inward/record.url?scp=0024593323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024593323&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 89

EP - 102

JO - Clinical Obstetrics and Gynecology

JF - Clinical Obstetrics and Gynecology

SN - 0009-9201

IS - 1

ER -